Read More Healthcare Industry News Lumos Diagnostics Holdings Limited puts FebriDx US rollout at centre of ASX:LDX rerating test Find out how Lumos Diagnostics Holdings is using FebriDx US adoption to test whether ASX:LDX can turn regulatory wins into revenue. bySrinathJune 11, 2026